{
    "clinical_study": {
        "@rank": "117893", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Evaluate the safety and efficacy of pallidotomy immediately following 3 preoperative\n      assessments vs. delayed pallidotomy following 6 months of standard medical therapy in\n      patients with Parkinson disease."
        }, 
        "brief_title": "Phase II Study of Pallidotomy for Parkinson Disease", 
        "condition": "Parkinson Disease", 
        "condition_browse": {
            "mesh_term": "Parkinson Disease"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a randomized study. One group of patients undergoes the surgical\n      procedure pallidotomy, a precise lesioning of brain cells in the globus pallidus.\n\n      The other group receives standard medical care for 6 months followed by a pallidotomy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Idiopathic Parkinson disease Hoehn and Yahr stage III or worse during \"off\" periods\n\n        Responsive to levodopa by history or exam Sub-optimal clinical response to maximal\n        medication Medication optimized for at least 4 weeks prior to entry\n\n        No atypical or secondary disease, e.g.:\n\n          -  No history of cerebrovascular accident\n\n          -  No cerebellar involvement\n\n          -  No severe brain atrophy on magnetic resonance imaging\n\n        No Mattis Dementia Rating Scale score less than 116\n\n        No dementia meeting Diagnostic and Statistical Manual of Mental Disorders-IV criteria\n\n        No Hamilton Depression Rating Scale score greater than 10\n\n        No Hamilton Anxiety Scale score greater than 14\n\n        --Patient Characteristics--\n\n        Other: No medical contraindication to surgery, e.g.:\n\n          -  Diabetes\n\n          -  Cardiopulmonary disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": "60", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004670", 
            "org_study_id": "199/12083", 
            "secondary_id": [
                "EUSM-018", 
                "EUSM-409-92"
            ]
        }, 
        "intervention": {
            "intervention_name": "pallidotomy", 
            "intervention_type": "Procedure"
        }, 
        "keyword": [
            "Parkinson disease", 
            "neurologic and psychiatric disorders", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Emory University", 
            "last_name": "Mahlon R. DeLong", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004670"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Emory University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "October 1994", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2001"
    }, 
    "geocoordinates": {}
}